Strasbourg Translational Neuroscience & Psychiatry - CRBS - Centre de recherche en biomédecine de Strasbourg

Top News

INSERM NeuroTechnologies

INSERM's NeuroTechnologies impulse programme was officially launched on 12 April 2024! The "Probing & Modulating the Brain Activity" project will enable the team to develop…

Psychiatry

Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD): Strasbourg is one of the leading cities in its detection and treatment! Links: https://www.inserm.fr/c-est-quoi/minute-datt…

Formal establishment of the INSERM UMR-S 1329 unit

INSERM unit UMR-S 1329, the result of the merger of ex-UMR-S 1114 & 1118, officially takes office on January 1st, 2024. This new INSERM multi-team is headed by Luc Dupuis and…

IF of the lateral hypothalamus a WT mouse and Sod1G86R mouse. In purple are labelled MCH+ neurons. Credits: Simon J Guillot

ALS-FTD

Hypothalamic hormone linked to metabolic dysregulation in ALS

This recent research shows that the loss of MCH+ hypothalamic neurons is linked to the metabolic problems that occur in ALS. Amyotrophic lateral sclerosis (ALS), also known as…

IF of spinal cord from ALS mouse model. In red are labelled motor neurons, in green NUP50. Credits: Sylvie Grosch

ALS-FTD

New genes linked to ALS

Work by Luc Dupuis' team has shown direct links between the genetics and anatomopathology of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). ALS is a disease of the…

News

Psychiatry

INSERM NeuroTechnologies

INSERM's NeuroTechnologies impulse programme was officially launched on 12 April 2024! The "Probing & Modulating the…

Psychiatry

Thesis Award: Psychiatry team

Does a multidimensional conception of apathy allow us to better understand its mechanisms ? : cognitive and…

Psychiatry

Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD): Strasbourg is one of the leading cities in its detection and treatment!…

Formal establishment of the INSERM UMR-S 1329 unit

INSERM unit UMR-S 1329, the result of the merger of ex-UMR-S 1114 & 1118, officially takes office on January 1st, 2024.…

ALS-FTD

Hypothalamic hormone linked to metabolic dysregulation in ALS

This recent research shows that the loss of MCH+ hypothalamic neurons is linked to the metabolic problems that occur in…

ALS-FTD

Establishment of an ALS patient cohort

The FG-COALS project - Franco-German cohort study on factors associated with weight loss in ALS - led by Luc Dupuis…

ALS-FTD

New genes linked to ALS

Work by Luc Dupuis' team has shown direct links between the genetics and anatomopathology of amyotrophic lateral…

Psychiatry

New illusion

The team has developed a new illusion that allows us to explore sensory predictions that we don't even know exist.

This jointly labelled research unit (UMR-S), established by INSERM and the University of Strasbourg, emerged from the integration of the former UMR-S 1114 (Kieffer & Giersch's lab) and UMR-S 1118 (Dupuis's lab).

Its main mission is the integration of the expertise of the three teams and the bridging of knowledge within this research unit.

The recently appointed Head of the Department is Dr Luc Dupuis, assisted by the co-directors of the teams within STEP, Dr Giersch for the Psychiatry team, Dr Lalanne & Dr Darcq for the Addictions team and Dr Rouaux for the ALS-FTD team.

For more detailed explanations on our teams, please visit their respective presentation page.

Top News

INSERM NeuroTechnologies

Attention-Deficit/Hyperactivity Disorder (ADHD)

Formal establishment of the INSERM UMR-S 1329 unit

Hypothalamic hormone linked to metabolic dysregulation in ALS

New genes linked to ALS